 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Integrated Diagnostics Forms New Division to House Imaging Business as PCC Development Continues
June 15, 2012
Integrated Diagnostics Forms New Division to House Imaging Business as PCC Development Continues
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Integrated Diagnostics Taking Aim at In Vivo Imaging, Therapeutics Markets with New PCC Reagents
October 28, 2011 / ProteoMonitor - GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - People in the News: Martin Latterich at BioScale; Norman Hardman at Integrated Diagnostics; and More
June 15, 2012 / ProteoMonitor - Agilent Partners with Integrated Diagnostics, Further Signaling Focus on MRM-MS as Clinical Platform
January 13, 2012 / ProteoMonitor - Stanford Scientists Using Phosphoprotein Profiling to Predict Oncogene Addiction, Drug Response
October 14, 2011 / ProteoMonitor